:covid-19: Sotrovimab Monoclonal Andtibodies
Contract Overview
Contract Amount: $1,597,461,996 ($1.6B)
Contractor: Glaxosmithkline, LLC
Awarding Agency: Department of Defense
Start Date: 2021-11-15
End Date: 2023-09-30
Contract Duration: 684 days
Daily Burn Rate: $2.3M/day
Official Description: :COVID-19: SOTROVIMAB MONOCLONAL ANDTIBODIES
Place of Performance
Location: North Carolina, 27709